应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
01349 复旦张江
未开盘 11-17 16:08:13
2.270
-0.075
-3.20%
最高
2.385
最低
2.270
成交量
99.80万
今开
2.310
昨收
2.345
日振幅
4.90%
总市值
23.54亿
流通市值
7.40亿
总股本
10.37亿
成交额
230.57万
换手率
0.31%
流通股本
3.26亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
智通AH统计|11月10日
智通财经 · 11-10
智通AH统计|11月10日
复旦张江:宫颈癌前病变项目及中重度痤疮项目已完成EOP2会议
证券之星 · 11-03
复旦张江:宫颈癌前病变项目及中重度痤疮项目已完成EOP2会议
复旦张江10月股份变动月报表,股本维持不变
公告速递 · 11-02
复旦张江10月股份变动月报表,股本维持不变
复旦张江(688505)2026年三季报简析:净利润同比增长341.02%,盈利能力上升
证券之星 · 10-31
复旦张江(688505)2026年三季报简析:净利润同比增长341.02%,盈利能力上升
复旦张江(688505)9月30日股东户数2.23万户,较上期增加6.88%
证券之星 · 10-30
复旦张江(688505)9月30日股东户数2.23万户,较上期增加6.88%
股市必读:上海医药新发布《上海医药集团股份有限公司关于与上海复旦张江生物医药股份有限公司续签《销售及分销协议》暨日常关联交易的公告》
证券之星 · 10-30
股市必读:上海医药新发布《上海医药集团股份有限公司关于与上海复旦张江生物医药股份有限公司续签《销售及分销协议》暨日常关联交易的公告》
复旦张江(01349)续签上海医药销售及分销协议 2027—2029年年度上限最高9,600万元
公告速递 · 10-29
复旦张江(01349)续签上海医药销售及分销协议 2027—2029年年度上限最高9,600万元
复旦张江(01349.HK)聘任樊开召为董事会秘书
智通财经 · 10-29
复旦张江(01349.HK)聘任樊开召为董事会秘书
复旦张江(01349.HK)聘任樊开召为公司董事会秘书
公告速递 · 10-29
复旦张江(01349.HK)聘任樊开召为公司董事会秘书
复旦张江(01349.HK)前三季度归母净利润3840.99万元
智通财经 · 10-29
复旦张江(01349.HK)前三季度归母净利润3840.99万元
复旦张江(01349)前三季度营收5.30亿元 归母净利3,841万元实现扭亏为盈
公告速递 · 10-29
复旦张江(01349)前三季度营收5.30亿元 归母净利3,841万元实现扭亏为盈
股市必读:复旦张江新发布《复旦张江关于召开2026年第三季度业绩说明会的公告》
证券之星 · 10-23
股市必读:复旦张江新发布《复旦张江关于召开2026年第三季度业绩说明会的公告》
复旦张江(688505)披露2026年第三季度业绩说明会安排,10月21日股价下跌0.4%
证券之星 · 10-21
复旦张江(688505)披露2026年第三季度业绩说明会安排,10月21日股价下跌0.4%
复旦张江(01349)将于10月30日举行2026年第三季度业绩说明会
公告速递 · 10-21
复旦张江(01349)将于10月30日举行2026年第三季度业绩说明会
复旦张江(688505)10月19日主力资金净买入60.15万元
证券之星 · 10-20
复旦张江(688505)10月19日主力资金净买入60.15万元
复旦张江(01349)拟于10月29日审议2026年前九个月未审计业绩
公告速递 · 10-15
复旦张江(01349)拟于10月29日审议2026年前九个月未审计业绩
复旦张江(688505)10月13日主力资金净卖出260.21万元
证券之星 · 10-14
复旦张江(688505)10月13日主力资金净卖出260.21万元
股市必读:复旦张江新发布《复旦张江H股公告》
证券之星 · 10-14
股市必读:复旦张江新发布《复旦张江H股公告》
股市必读:复旦张江新发布《复旦张江H股公告》
证券之星 · 10-13
股市必读:复旦张江新发布《复旦张江H股公告》
复旦张江(01349)认购4亿元平安银行结构性存款产品
智通财经 · 10-12
复旦张江(01349)认购4亿元平安银行结构性存款产品
加载更多
公司概况
公司名称:
复旦张江
所属市场:
SEHK
上市日期:
--
主营业务:
上海复旦张江生物医药股份有限公司是一家主要从事生物医药的研究开发、生产制造和市场营销业务的中国公司。该公司的产品包括盐酸氨酮戊酸外用散和注射用海姆泊芬,以及长循环盐酸多柔比星脂质体注射液。该公司的产品主要用于皮肤性病治疗和抗肿瘤治疗。该公司主要在中国国内市场开展业务。
发行价格:
--
{"stockData":{"symbol":"01349","market":"HK","secType":"STK","nameCN":"复旦张江","latestPrice":2.27,"timestamp":1794902893208,"preClose":2.345,"halted":0,"volume":998000,"delay":0,"changeRate":-0.031982942430703695,"floatShares":326000000,"shares":1036999999,"eps":-0.17877055351804336,"marketStatus":"未开盘","change":-0.075,"latestTime":"11-17 16:08:13","open":2.31,"high":2.385,"low":2.27,"amount":2305650,"amplitude":0.049041,"askPrice":2.285,"askSize":7000,"bidPrice":2.27,"bidSize":3000,"shortable":0,"etf":0,"ttmEps":-0.10468300979261318,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1794965400000},"marketStatusCode":0,"adr":0,"listingDate":1029168000000,"exchange":"SEHK","adjPreClose":2.345,"nav":14475,"aum":448017213600,"bidAskSpread":0,"openAndCloseTimeList":[[1794879000000,1794888000000],[1794891600000,1794902400000]],"volumeRatio":1.3176656985290247,"lotSize":1000,"spreadScale":0,"tradeCurrency":"HKD","astockBrief":{"symbol":"688505","market":"SH","secType":"STK","nameCN":"复旦张江","latestPrice":6.65,"timestamp":1794898800000,"preClose":6.75,"halted":0,"volume":4446100,"delay":0,"premium":"-71.00"}},"requestUrl":"/m/hq/s/01349","defaultTab":"news","newsList":[{"id":"2682623393","title":"智通AH统计|11月10日","url":"https://stock-news.laohu8.com/highlight/detail?id=2682623393","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2682623393?lang=zh_cn&edition=full","pubTime":"2026-11-10 16:15","pubTimestamp":1794298504,"startTime":"0","endTime":"0","summary":"东北电气0.2012.251243.28%-5.51%晨鸣纸业0.4251.86424.71%69.45%浙江世宝3.48015.05418.10%7.50%凯盛新能1.8056.92359.28%9.14%弘业期货1.9057.13348.29%-7.78%京城机电股份2.4258.29309.48%26.57%中石化油服0.6402.07287.50%-6.77%南京熊猫电子股份2.9259.38284.27%-1.71%广和通6.67521.35283.07%22.05%钧达股份15.40048.9280.32%-12.46%. 兆威机电33.960107277.39%82.65%晨鸣纸业0.4251.86424.71%69.45%蓝思科技14.66029.17138.34%40.37%京城机电股份2.4258.29309.48%26.57%中芯国际47.240107.75173.20%26.30%长飞光纤光缆89.700252.33236.95%22.63%广和通6.67521.35283.07%22.05%大族数控50.200140.48235.20%22.00%龙旗科技19.39040.12147.86%21.75%长城汽车6.20513.77165.75%19.63%. 备注:以上数据由智通机器人根据港交所数据,经过人工智能运算后自动生成,并不保证数据100%准确;偏离值为当前溢价率与该股过去30天平均溢价率的差值。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1521021.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01033","01108","03143","01812","02333","03200","02384","03968","00956","00300","03678","00981","601633","03750","01276","159982","02338","01349","03308","02245","00638","02603","00916","02823","02692","00042","01057","07233","00187","02899","EWH","02865","82333","03986","06613","03369","00588","02827","02768","03328","GWLLY","09611","02822","03661","02359","03188","06869","399300","00553"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680744191","title":"复旦张江:宫颈癌前病变项目及中重度痤疮项目已完成EOP2会议","url":"https://stock-news.laohu8.com/highlight/detail?id=2680744191","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2680744191?lang=zh_cn&edition=full","pubTime":"2026-11-03 18:21","pubTimestamp":1793701294,"startTime":"0","endTime":"0","summary":"局部用盐酸氨酮戊酸散用于治疗HPV感染的宫颈癌前病变项目及盐酸氨酮戊酸外用散用于治疗中重度痤疮项目,均已完成II期临床试验,其阶段性研究结果分别已在中华医学会第十八次妇科肿瘤学学术会议、第五十三届欧洲皮肤研究协会年会上公开发表。目前,上述项目已完成与监管方临床学科沟通会,公司正根据与监管的沟通情况,有序推进相关工作。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026110300035751.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1191","688505","BK0239","01349"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1125513630","title":"复旦张江10月股份变动月报表,股本维持不变","url":"https://stock-news.laohu8.com/highlight/detail?id=1125513630","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1125513630?lang=zh_cn&edition=full","pubTime":"2026-11-02 17:04","pubTimestamp":1793610284,"startTime":"0","endTime":"0","summary":"2026年11月2日,上海复旦张江生物医药股份有限公司发布2026年10月股份变动月报表。公告显示,报告期内公司注册股本无发生任何变动。两类股份累计注册股本为人民币103,657,210元,与上月保持一致。截至2026年10月31日,公司当月未进行任何新增发行、购回或注销股份,也未出现库藏股变动以及股权激励计划事项。各类股份总数与上月底相同,股本结构保持稳定。公司表示,将继续遵守香港联交所《上市规则》及相关法律法规。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01349"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679822239","title":"复旦张江(688505)2026年三季报简析:净利润同比增长341.02%,盈利能力上升","url":"https://stock-news.laohu8.com/highlight/detail?id=2679822239","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679822239?lang=zh_cn&edition=full","pubTime":"2026-10-31 11:35","pubTimestamp":1793417746,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理,近期复旦张江发布2026年三季报。截至本报告期末,公司营业总收入5.3亿元,同比下降3.88%,归母净利润3840.99万元,同比上升341.02%。按单季度数据看,第三季度营业总收入1.57亿元,同比下降2.18%,第三季度归母净利润151.49万元,同比上升107.0%。本报告期复旦张江盈利能力上升,毛利率同比增幅1.64%,净利率同比增幅346.36%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026103100024603.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688505","01349"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679218004","title":"复旦张江(688505)9月30日股东户数2.23万户,较上期增加6.88%","url":"https://stock-news.laohu8.com/highlight/detail?id=2679218004","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679218004?lang=zh_cn&edition=full","pubTime":"2026-10-30 19:13","pubTimestamp":1793358816,"startTime":"0","endTime":"0","summary":"证券之星消息,近日复旦张江披露,截至2026年9月30日公司股东户数为2.23万户,较6月30日增加1435.0户,增幅为6.88%。在化学制药行业个股中,复旦张江股东户数低于行业平均水平,截至9月30日,化学制药行业平均股东户数为3.98万户。从股价来看,2026年6月30日至2026年9月30日,复旦张江区间涨幅为15.85%,在此期间股东户数增加1435.0户,增幅为6.88%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026103000046782.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","01349","688505","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679423730","title":"股市必读:上海医药新发布《上海医药集团股份有限公司关于与上海复旦张江生物医药股份有限公司续签《销售及分销协议》暨日常关联交易的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2679423730","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679423730?lang=zh_cn&edition=full","pubTime":"2026-10-30 05:48","pubTimestamp":1793310512,"startTime":"0","endTime":"0","summary":"公司公告汇总上海医药集团股份有限公司关于与上海复旦张江生物医药股份有限公司续签《销售及分销协议》暨日常关联交易的公告2026年10月29日,上海医药与复旦张江续签《销售及分销协议》,有效期自2027年1月1日至2029年12月31日;2027年至2029年每年协议项下销售金额分别不超过8,600万元、9,000万元和9,600万元;交易按市场化定价原则进行,已获公司董事会审议通过,尚需复旦张江股东会批准。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026103000008978.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688505","399441","02607","BK0184","BK1197","601607","161726","BK0239","BK0175","BK0188","BK0012","BK0097","BK1191","BK0020","BK0183","BK0187","BK0196","BK0209","BK0099","01349","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1117488911","title":"复旦张江(01349)续签上海医药销售及分销协议 2027—2029年年度上限最高9,600万元","url":"https://stock-news.laohu8.com/highlight/detail?id=1117488911","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1117488911?lang=zh_cn&edition=full","pubTime":"2026-10-29 19:22","pubTimestamp":1793272927,"startTime":"0","endTime":"0","summary":"复旦张江生物医药股份有限公司10月29日收市后公告,与主要股东上海医药集团股份有限公司于2026年10月29日签订新的《销售及分销协议》,以续展原协议,合同期自2027年1月1日至2029年12月31日。根据协议,复旦张江授权上海医药及其附属公司、联属人士在合约期内非独家销售及分销集团的医药产品,目前涵盖艾拉及里葆多,未来如有新增产品亦适用同一协议条款。2027年度不超过8,600万元;2028年度不超过9,000万元;","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01349"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679702504","title":"复旦张江(01349.HK)聘任樊开召为董事会秘书","url":"https://stock-news.laohu8.com/highlight/detail?id=2679702504","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679702504?lang=zh_cn&edition=full","pubTime":"2026-10-29 18:53","pubTimestamp":1793271199,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["01349","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1131601508","title":"复旦张江(01349.HK)聘任樊开召为公司董事会秘书","url":"https://stock-news.laohu8.com/highlight/detail?id=1131601508","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1131601508?lang=zh_cn&edition=full","pubTime":"2026-10-29 18:51","pubTimestamp":1793271077,"startTime":"0","endTime":"0","summary":"2026年10月29日,上海复旦张江生物医药股份有限公司召开第九届董事会第三次会议,以8票同意、0票反对、0票弃权的表决结果通过《关于聘任董事会秘书的议案》,决定聘任樊开召先生担任公司董事会秘书。任期自董事会审议通过之日起至第九届董事会届满之日止。公司董事会主席赵大君先生不再代行董事会秘书职责。2026年7月,樊开召先生加入复旦张江担任董事会秘书办公室经理。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01349"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679447109","title":"复旦张江(01349.HK)前三季度归母净利润3840.99万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2679447109","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679447109?lang=zh_cn&edition=full","pubTime":"2026-10-29 18:01","pubTimestamp":1793268085,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1191","01349"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1192202400","title":"复旦张江(01349)前三季度营收5.30亿元 归母净利3,841万元实现扭亏为盈","url":"https://stock-news.laohu8.com/highlight/detail?id=1192202400","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1192202400?lang=zh_cn&edition=full","pubTime":"2026-10-29 18:00","pubTimestamp":1793268052,"startTime":"0","endTime":"0","summary":"2026年10月29日,上海复旦张江生物医药股份有限公司公布截至2026年9月30日止第三季度及前三季度未经审计业绩。数据显示,公司在研发投入收缩及费用控制下,实现盈利能力显著改善。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01349"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677960199","title":"股市必读:复旦张江新发布《复旦张江关于召开2026年第三季度业绩说明会的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2677960199","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677960199?lang=zh_cn&edition=full","pubTime":"2026-10-23 04:11","pubTimestamp":1792699871,"startTime":"0","endTime":"0","summary":"截至2026年10月22日收盘,复旦张江报收于7.26元,下跌2.68%,换手率0.84%,成交量5.96万手,成交额4361.12万元。当日关注点交易信息汇总:10月22日主力资金净流出173.16万元,占总成交额3.97%。公司公告汇总:复旦张江将于2026年10月30日上午11:00-12:00召开2026年第三季度业绩说明会,通过上证路演中心网络互动方式进行。投资者可于2026年10月23日至10月29日16:00前通过上证路演中心网站或公司邮箱ir@fd-zj.com提问。会后可通过上证路演中心查看会议情况。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102300004281.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","01349","BK1191","688505"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677670153","title":"复旦张江(688505)披露2026年第三季度业绩说明会安排,10月21日股价下跌0.4%","url":"https://stock-news.laohu8.com/highlight/detail?id=2677670153","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677670153?lang=zh_cn&edition=full","pubTime":"2026-10-21 22:37","pubTimestamp":1792593434,"startTime":"0","endTime":"0","summary":"截至2026年10月21日收盘,复旦张江报收于7.46元,较前一交易日下跌0.4%,最新总市值为77.33亿元。近日,复旦张江发布《关于召开2026年第三季度业绩说明会的公告》。公告显示,公司将于2026年10月30日上午11:00-12:00通过上证路演中心网络互动方式召开2026年第三季度业绩说明会,介绍公司经营成果及财务状况。投资者可于2026年10月23日至10月29日16:00前通过上证路演中心网站或公司邮箱ir@fd-zj.com提问。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102100041617.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688505","BK1191","BK0239","01349"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1150679871","title":"复旦张江(01349)将于10月30日举行2026年第三季度业绩说明会","url":"https://stock-news.laohu8.com/highlight/detail?id=1150679871","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1150679871?lang=zh_cn&edition=full","pubTime":"2026-10-21 17:06","pubTimestamp":1792573593,"startTime":"0","endTime":"0","summary":"届时,公司将在上海证券交易所网站披露《上海复旦张江生物医药股份有限公司2026年第三季度报告》,并就经营成果及财务指标等投资者关注事项开展网络互动交流。投资者可于2026年10月23日至10月29日16:00前,通过上证路演中心“提问预征集”栏目或公司邮箱ir@fd-zj.com提交问题。会议结束后,投资者可登陆上证路演中心查看回放及主要内容。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01349"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2676637571","title":"复旦张江(688505)10月19日主力资金净买入60.15万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2676637571","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2676637571?lang=zh_cn&edition=full","pubTime":"2026-10-20 08:31","pubTimestamp":1792456309,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2026年10月19日收盘,复旦张江报收于7.27元,下跌3.07%,换手率1.45%,成交量10.3万手,成交额7532.86万元。近5日资金流向一览见下表:复旦张江融资融券信息显示,融资方面,当日融资买入599.51万元,融资偿还594.41万元,融资净买入5.1万元。复旦张江主营业务:主要从事生物医药的创新研究开发、生产制造和市场营销。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102000005371.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688505","01349","BK1191","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1174873393","title":"复旦张江(01349)拟于10月29日审议2026年前九个月未审计业绩","url":"https://stock-news.laohu8.com/highlight/detail?id=1174873393","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1174873393?lang=zh_cn&edition=full","pubTime":"2026-10-15 17:40","pubTimestamp":1792057233,"startTime":"0","endTime":"0","summary":"上海复旦张江生物医药股份有限公司(01349)10月15日公告,公司董事会将于2026年10月29日(星期四)召开会议,审议并通过包括截至2026年9月30日止九个月期间的未审计业绩及其发布等事项。\n公告显示,截至公告发布日,董事会成员包括执行董事赵大君先生、薛燕女士,非执行董事钟涛先生、余晓阳女士,独立非执行董事王宏广先生、林兆荣先生、徐培龙先生,以及职工董事曲亚楠女士。\n香港交易及结算所有限公司及香港联合交易所有限公司对本公告内容概不负责,并对其准确性或完整性不发表任何声明。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01349"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675439684","title":"复旦张江(688505)10月13日主力资金净卖出260.21万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2675439684","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675439684?lang=zh_cn&edition=full","pubTime":"2026-10-14 08:29","pubTimestamp":1791937754,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2026年10月13日收盘,复旦张江报收于7.96元,下跌2.45%,换手率1.44%,成交量10.24万手,成交额8120.96万元。近5日资金流向一览见下表:复旦张江融资融券信息显示,融资方面,当日融资买入617.7万元,融资偿还503.75万元,融资净买入113.95万元。复旦张江主营业务:主要从事生物医药的创新研究开发、生产制造和市场营销。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101400007253.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1191","01349","688505","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675361742","title":"股市必读:复旦张江新发布《复旦张江H股公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2675361742","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675361742?lang=zh_cn&edition=full","pubTime":"2026-10-14 02:52","pubTimestamp":1791917529,"startTime":"0","endTime":"0","summary":"公司公告汇总复旦张江H股公告本公司与平安银行订立结构性存款产品协议,使用自有闲置资金人民币4.00亿元认购保本浮动收益型结构性存款产品,产品期限为80天,预期年化收益率区间为0.45%-1.75%,挂钩标的为中债十年期国债到期收益率。该交易构成须予披露的交易,已获董事会批准,无需独立股东批准。董事认为交易按正常商业条款订立,符合公司及股东整体利益。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101400002020.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1191","01349","688505","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675802902","title":"股市必读:复旦张江新发布《复旦张江H股公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2675802902","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675802902?lang=zh_cn&edition=full","pubTime":"2026-10-13 02:47","pubTimestamp":1791830829,"startTime":"0","endTime":"0","summary":"公司公告汇总复旦张江H股公告上海复旦张江生物医药股份有限公司与浦发银行订立结构性存款产品协议,使用自有闲置资金人民币2.10亿元认购保本浮动收益型结构性存款产品,产品期限为81天,预期年化收益率区间为1.00%-1.95%,挂钩标的为欧元兑美元汇率。该交易构成须予披露的交易,已获董事会批准,无需独立股东批准。董事认为交易按正常商业条款订立,符合公司及股东整体利益。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101300002205.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK1191","688505","01349"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674387969","title":"复旦张江(01349)认购4亿元平安银行结构性存款产品","url":"https://stock-news.laohu8.com/highlight/detail?id=2674387969","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674387969?lang=zh_cn&edition=full","pubTime":"2026-10-12 18:09","pubTimestamp":1791799754,"startTime":"0","endTime":"0","summary":"智通财经APP讯,复旦张江(01349)发布公告,近日,本公司与平安银行订立平安银行结构性存款产品协议,同意以日常营运产生的自有闲置资金向平安银行认购金额为人民币4.00亿元的结构性存款产品。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1506009.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0188","LU1993786604.SGD","BK0201","BK0278","LU0072913022.USD","LU1781817850.SGD","688505","LU1580142542.USD","BK0012","BK0028","BK1191","01349","BK0183","LU0501845795.SGD","BK0187","LU0880133367.SGD","LU1655091616.SGD","LU0067412154.USD","LU1226287529.USD","BK0239","LU1807302812.USD","IE00B0JY6N72.USD","000001"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.fd-zj.com","stockEarnings":[{"period":"1week","weight":-0.0462},{"period":"1month","weight":-0.0754},{"period":"3month","weight":-0.1115},{"period":"6month","weight":-0.1303},{"period":"1year","weight":-0.3079},{"period":"ytd","weight":-0.1835}],"compareEarnings":[{"period":"1week","weight":-0.0427},{"period":"1month","weight":-0.0281},{"period":"3month","weight":-0.0779},{"period":"6month","weight":-0.074},{"period":"1year","weight":-0.109},{"period":"ytd","weight":-0.0828}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"上海复旦张江生物医药股份有限公司是一家主要从事生物医药的研究开发、生产制造和市场营销业务的中国公司。该公司的产品包括盐酸氨酮戊酸外用散和注射用海姆泊芬,以及长循环盐酸多柔比星脂质体注射液。该公司的产品主要用于皮肤性病治疗和抗肿瘤治疗。该公司主要在中国国内市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.384615,"avgChangeRate":0.001416},{"month":2,"riseRate":0.461538,"avgChangeRate":0.014509},{"month":3,"riseRate":0.384615,"avgChangeRate":0.022365},{"month":4,"riseRate":0.615385,"avgChangeRate":0.030203},{"month":5,"riseRate":0.461538,"avgChangeRate":0.007287},{"month":6,"riseRate":0.307692,"avgChangeRate":-0.033999},{"month":7,"riseRate":0.461538,"avgChangeRate":0.012968},{"month":8,"riseRate":0.384615,"avgChangeRate":-0.043856},{"month":9,"riseRate":0.538462,"avgChangeRate":0.014086},{"month":10,"riseRate":0.384615,"avgChangeRate":-0.016093},{"month":11,"riseRate":0.538462,"avgChangeRate":0.013647},{"month":12,"riseRate":0.333333,"avgChangeRate":-0.017318}],"exchange":"SEHK","name":"复旦张江","nameEN":"FUDANZHANGJIANG"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.54.0","shortVersion":"4.54.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"复旦张江(01349)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供复旦张江(01349)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"复旦张江,01349,复旦张江股票,复旦张江股票老虎,复旦张江股票老虎国际,复旦张江行情,复旦张江股票行情,复旦张江股价,复旦张江股市,复旦张江股票价格,复旦张江股票交易,复旦张江股票购买,复旦张江股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"复旦张江(01349)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供复旦张江(01349)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}